Management

W. Paul Mar Ph.D., CEO

W. Paul Mar, Ph.D.in organic chemistry, Shanghai Institute of Organic Chemistry, post-doctoral research at Northwestern University, CEO of SynChem-Formosa, Inc., has over 40 years of experience in CRO/CDMO, including as one of the founders of SynChem, inc.

Daniel Fang M.S., COO

Daniel Fang, M.S. in organic chemistry, Chengdu Institute of Organic Chemistry, researcher in IUPUI, COO of SynChem-Formosa, Inc., has over 40 years’ experience in CDMO and contract research organizations, including as one of the founders of SynChem, Inc.

Chandler W. Huang Ph.D., CTO

Chandler W. Huang, Ph.D. in organic chemistry, University of Notre Dame, CTO of SynChem-Formosa, Inc., has over 30 years drug discovery and contract research, including as CEO for PfotoLand Therapeutics and PracticaChem LLC.

Jan W.F. Wasley, Chairman of Scientific Advisory Board

Jan W.F. Wasley, Ph.D., held several managerial positions in pharmaceutical industry, including The Institutes of Pharmaceutical Discovery in Branford Connecticut, Neurogen and Ciba-Geigy. 

Richard B. Silverman, Scientific Advisory Board

Richard B. Silverman, Ph.D., is a Charles Deering McCormick Professor in the Department of Chemistry at Northwestern University. Professor Silverman is a leader of organic and medicinal research in Chemistry, particularly in the field of molecular mechanisms of action, rational design, and syntheses of potential medicinal agents that act as specific enzyme inhibitors.